Today’s AI Top Pick: TMDX

7/8/2026 · Swing Setup screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Swing SetupTMDXBUY NOW8.7 / 107/8/2026

TransMedics (TMDX) is the cleanest 'coiled spring' in this pool: fundamentals PLUS a tape that just turned. It cleared the screen with a PE of 16.3, fwdPE 21.65, ROE 45.22%, profit margin 27.04%, sales growth 30.24% Y/Y and next-year EPS growth of 70.83% — that's a rare combination of growth AND real profitability among these names, backed by an analyst recom of 1.64 and 63.4% target upside. Unlike the beat-up commodity/gold names in the pool, TMDX is a genuine growth compounder that has already taken its pain (perf YTD -41.54%, perf year -43.18%, weekly drawdown -52.36% from the 21-bar high, weekly position in range just 7.31%). The forecast tape confirms the reversal in a way very few candidates match: 1d fc_short +52.37%, fc_mid +70.87%, fc_long +59.85%; 4h fc_mid +80.4%, fc_long +97.52%; 1h fc_long +56.22%. Bullish_prob is 1.0 and near_term_bullish is 1.0 — the highest tier in the set. Crucially, price sits at only 22.47% of the daily 21-bar range and 27.84% of the 4h range, so we are NOT chasing a top — the setup is a base attempt after a violent purge, exactly what you want for a swing entry. News is supportive rather than a landmine: Evercore ISI reiterated Outperform (only trimmed target to $90 = ~30% upside from spot 69.20), and Motley Fool listed it among '3 Growth Stocks to Buy on the Dip.' Compare that to FUTU (DOJ probe + class actions — I'm penalizing it despite better valuation), STEP (Hunterbrook/Bear Cave short report flagging $2.3B liability — avoid), CALX (stretched to 91.98% of 1d range plus a class action deadline), and KTOS (weekly forecasts are outright negative: -23.77% / -40.28%). TMDX has no such overhang. Today is the right entry because we're catching a still-depressed name with the highest forecast magnitudes in the pool, low position-in-range (asymmetric risk/reward), full bullish probability, and no material news catalyst against us. Waiting risks buying after the 1d forecast starts to compress into price.

Entry zone

$67.50–$70.00 (starter at market ~$69.20, add on dip to $67-$68 gap fill)

Stop loss

$61.50 (below the weekly range low; ~11% risk — appropriate for a name that has already taken a -52% weekly drawdown)

First target

$79 (recent 21-bar daily high, ~+14%)

Longer target

$92–$100 (aligns with Evercore's $90 PT and the 4h/1d fc_mid magnitudes of +70–80%, ~+35-45%)

Risks

High short float of 23.02% — squeeze potential is a plus, but heavy shorts often reflect real bear thesis (organ transport unit economics, competitive pressure)
Debt/Equity of 1.75 is the highest among top-tier picks and constrains flexibility if revenue growth slows
Weekly trend still deeply damaged (-48.45% recent 21-bar, -52.36% from high) — a failed base could see another leg lower before recovery
1h fc_short of only +0.26% suggests near-term chop before the bigger move; expect volatility around the $67-$70 zone
Analyst recom 1.64 is the weakest among the top 5 candidates; if Evercore-style PT trims continue, sentiment could stall the rebound

Honorable mentions

HSAIBullish_prob 1.0, position 38% of daily range (not stretched), 1d fc_short +35.63%, fc_long +41.84%, PEG 0.43, sales +44% Y/Y, EPS next Y +68.6%. Clean news (positive lidar/insider ownership coverage). Slight downgrade vs TMDX because 1wk forecasts are muted (+1.75% to +4.43%) and China ADR overhang.

VNETBullish_prob 1.0, near_term_bullish 1.0, Deutsche Bank just initiated Buy with $12.5 PT vs spot $7.93 (+58%), 1d fc_short +16.78%, position only 22.95% of daily range. Held back by weak fundamentals (fundamental_score -0.25, debt/equity 7.03, negative profit margin -22.14%).

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	TMDX	BUY NOW	8.7	Best fundamentals-plus-tape combo: 1d fc +52%, position 22% of range, bullish_prob 1.0, profit margin 27%, no news landmines.
2	HSAI	BUY NOW	8.0	PEG 0.43, sales +44%, 1d fc_short +35.6% with position at 38% of range; only weekly forecast is muted.
3	VNET	BUY NOW	7.4	Fresh Deutsche Bank Buy with $12.5 PT, bullish_prob 1.0, low position-in-range — but leveraged balance sheet.
4	FUTU	BUY PULLBACK	6.8	PE 10.3, ROE 28%, huge 1d fc +46.58%, but DOJ probe + class actions are a material overhang — wait for clarity or a lower entry.
5	SRAD	BUY PULLBACK	6.5	Fundamental_score 8 and near_term_bullish 1.0, but 1h/1wk forecasts are negative (-11.94%, -10.79%) — mixed multi-TF picture.
6	CELH	BUY PULLBACK	6.2	1d fc_mid +42%, sales +123%, but 1h position at 0% of range signals immediate weakness; wait for base.
7	KRMN	BUY PULLBACK	6.0	4h fc_long +75%, 1d +47.9%, target upside 101%, but weekly forecasts null and PS 13.05 is stretched.
8	CALX	WAIT	5.9	1d fc +25% but already at 91.98% of daily range — chasing risk; class action headline as minor drag.
9	GIL	WAIT	5.5	Fundamental_score 8 and clean news, but weekly forecasts are all negative (-6.25%/-13.86%/-7.62%) — trend deteriorating.
10	AVAV	WAIT	5.3	4h fc_long +84.88% is compelling, but stock 'dived >20% last month' and 1h at 7.46% of range — falling knife.
11	KTOS	WAIT	5.0	Positive contract news but weekly fc_short -23.77% and fc_mid -40.28% — model expects more downside.
12	DNOW	WAIT	5.0	Multiple broker initiations at Buy, but forecast magnitudes are small (<10%) across all timeframes.
13	CAI	WAIT	4.8	1d fc_long +60%, but bullish_prob null, weekly forecasts null, profit margin -45.35% — high uncertainty.
14	BMNR	WAIT	4.7	ETH-treasury play, weekly forecasts all zero, PS 504, profit margin -51,998% — pure narrative bet, not a fundamentals trade.
15	HMY	WAIT	4.5	PEG 0.09 and ROE 33% look great, but weekly forecasts all deeply negative (-17% to -33%) — gold thesis breaking down.
16	VFS	WAIT	4.3	Bullish_prob 1.0 but weekly fc -8% to -21% and profit margin -110% — speculative EV story with competition warnings.
17	BULL	WAIT	4.2	M&A tailwind (Pi Securities), but SeekingAlpha flags 'still has a problem' and above-fair-value tag; profit margin -81.59%.
18	LEGN	WAIT	4.0	Clinical wins, but 4h fc_long -34.92% and 1d fc_long -6.9%; bullish_prob only 0.2.
19	STEP	AVOID	3.8	Hunterbrook/Bear Cave short report flags $2.3B liability — thesis is compromised regardless of forecast.
20	EXK	AVOID	3.7	Weekly fc_short -30%, fc_mid -44.59%, fc_long -35.67% — model is emphatically bearish.
21	BKV	AVOID	3.5	Bullish_prob 0, near-term 0.2, at 91.69% of daily range, dilution-fear headline — sell setup, not a buy.
22	MNDY	WAIT	3.5	Positive AI/buyback news, but no forecast data (expected_return null) and RSI 61.5 near screen ceiling.
23	SUPN	AVOID	3.3	Bullish_prob 0, RSI 59.5 extended, StockStory flags '3 reasons to avoid' — momentum without support.
24	AG	AVOID	3.0	Weekly fc_short -29.32%, fc_mid -57.95%; bullish_prob 0 — silver breakdown continuing.
25	ARIS	AVOID	2.8	1d fc_long -34.28%, weekly fc_mid -71.83%, on 'New Strong Sell' list — despite strong Q2 production.
26	TPC	AVOID	2.7	Weekly fc_mid -73.23%, 'rally getting stretched' per Simply Wall St; bullish_prob 0.
27	TGB	AVOID	2.5	Weekly fc_mid -65.62%, fc_long -57.31%; PE 233, profit margin 1.99% — expensive and breaking down.
28	RGEN	AVOID	2.5	PE 154, PEG 2.24, RSI 58.8, StockStory '3 Reasons Risky' — screen-borderline with poor risk/reward.
29	LC	AVOID	2.3	All forecast horizons negative on every timeframe (1d fc_long -21.53%, 1wk -37.71%); bullish_prob 0.
30	HAPN	AVOID	2.2	At 90.4% of weekly range with 1d fc_short -16.14% and fc_long -23.98% — classic distribution top.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord